Morphine Sulfate
Product Images NDC 0409-1135

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0409-1135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

FDA Label Image

Logo (Morphine 02)

FDA Label Image

Principal Display Panel (1000 mg/20 mL Vial Label)

Principal Display Panel (1000 mg/20 mL Vial Label)
Morphine sulfate injection, USP is a single-dose flip top vial for intravenous use only, with a concentration of 1000 mg/20mL. The medication is intended for dilution only, not for direct injection. The product contains sulfites and is only used for intravenous purposes, and discarded after use. Proper storage and handling should be followed.*
FDA Label Image

Principal Display Panel (1000 mg/20 mL Vial Carton)

Principal Display Panel (1000 mg/20 mL Vial Carton)
The text is describing a medication called Morphine Sulfate Injection, USP. It comes in single-dose vials with each mL containing 50mg of morphine sulfate, edetate disodium 0.75mg, sodium metabisulfite 1mg and sulfuric acid. The injection is for intravenous use only and must be diluted before use. The medication's usual dosage is provided in an insert. Unused portions must be discarded, and the injection should not be darker than pale yellow or contain a precipitate. The manufacturer is Hospira, Inc., located in Lake Forest, IL, USA.*
FDA Label Image

Principal Display Panel (2500 mg/50 mL Vial Label)

Principal Display Panel (2500 mg/50 mL Vial Label)
This is a description of a medication labeled NDC 0409-1134-05 which contains Morphine sulfate, edetate disodium, sodium metabisulfite, and sulfuric acid. It is a single-dose flip-top vial with 50 mL liquid medication that should be discarded if unused after opening. The usual dosage is not specified, but it is advised to follow the instructions in the insert. It should be kept at room temperature and protected from light. It is not suitable for intrathecal or epidural use and caution is advised for dilution use only. It is produced by Hospira, Inc. and should not be used if it has any discoloration or precipitate. The barcode on the label is 0 030409 113405 8.*
FDA Label Image

Principal Display Panel (2500 mg/50 mL Vial Carton)

Principal Display Panel (2500 mg/50 mL Vial Carton)
This is a description of a medication which contains morphine sulfate, edetate disodium, and sodium metabisulfite. The pH level is adjusted with sulfuric acid and the medication comes in mL dosages. The packaging warns the medication should be discarded if discolored or if there is a precipitate. There is also caution against direct injection and instructions to store in a controlled room temperature environment. The medication is manufactured by Hospira, Inc.*
FDA Label Image

Principal Display Panel (250 mg Vial Label)

Principal Display Panel (250 mg Vial Label)
This is a single-dosage vial containing 25 mg of morphine sulfate in 1 mL solution, with sulfuric acid for pH adjustment. It is suggested to refer to the insert for usual dosage and should not be used if injection contains a precipitate. The vial is preservative-free and should not be directly injected; it should be diluted before use. It is cautioned that this medication may be habit-forming. It should be stored at 20 to 25°C, protected from light. This product is distributed by Hospira, Inc., based in Lake Forest, IL, 60045 USA.*
FDA Label Image

Principal Display Panel (250 mg Vial Carton)

Principal Display Panel (250 mg Vial Carton)
This text appears to be a label/information sheet for an injection drug called "Morphine Sulfate". It contains handling and usage precautions, dosage information, and storage instructions. The text also warns of the drug's addictive properties and that it should not be injected directly.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.